We are incredibly excited and humbled to announce that Epi One has now surpassed the $1 million mark in our equity crowding campaign on StartEngine. Epi One ranks among the top 15 campaigns on the platform in terms of funds raised, and including our previous investment rounds, we have now raised more than $4.1 million.
To have raised over $1 million from crowdfunding is a huge milestone in our journey to revolutionize early cancer detection and make it accessible to everyone. As Epi One CEO Michael Marquardt says: “Accurate and affordable early cancer detection is within reach!”
“When we set out to build excitement for our scientific discovery, and to raise necessary funding, we did not think that we would surpass the $1 million mark so quickly. And that we would have close to 200 investors already”, he adds. “This early support means we can accelerate our research timetable and bring our tests to market earlier than we had hoped.”
We firmly believe that the progress we are making in our laboratory will in future be talked about as one of the great discoveries that changed the face of cancer care forever. Our mission is to make a profound impact in the health technology sector, and every investment brings us closer to that goal. The funds raised are enabling us to complete clinical validation of our testing platform for additional cancer types and to further expand our laboratory space.
The equity crowdfunding campaign is live on StartEngine until 21 October 2024. If you are passionate about innovation in healthcare and want to be a part of something meaningful, now is your chance to invest in Epi One.
